• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

3.490 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nkarta, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
April 15, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in Needham Virtual Healthcare Conference
April 09, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
March 25, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in March Investor Conferences
February 27, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in Evercore Healthcare Conference
December 02, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 10, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in November Investor Conferences
October 30, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
October 22, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 12, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
June 06, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
May 14, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
March 26, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
December 05, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
November 07, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 13, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 13, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
July 16, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
June 27, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
May 09, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
April 08, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
April 05, 2024
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
April 05, 2024
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Nkarta Announces Pricing of $240 Million Underwritten Offering
March 25, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
December 09, 2023
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
November 09, 2023
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024
From FN Media Group LLC
Via GlobeNewswire
News headline image
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
October 17, 2023
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures
October 16, 2023
Call scheduled for Tuesday, October 17, 2023 at 8:00 a.m. ET 
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
August 10, 2023
From Nkarta, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap